Dr Belinda Kiely

Senior Research Fellow
NHMRC Clinical Trials Centre, Sydney Medical School

T: +61 2 9562 5043
F: +61 2 9565 1863


2014 | 2013 | 2012 | 2011


  • West, T., Kiely, B., Stockler, M. (2014), Estimating scenarios for survival time in men starting systemic therapies for castration-resistant prostate cancer: A systematic review of randomised trials. European Journal of Cancer. 50(11), 1916-1924. [Abstract]


  • Kiely, B., Martin, A., Tattersall, M., Nowak, A., Goldstein, D., Wilcken, N., Wyld, D., Abdi, E., Glasgow, A., Beale, P., Jefford, M., Glare, P., Stockler, M. (2013), The Median Informs the Message: Accuracy of Individualized Scenarios for Survival Time Based on Oncologists' Estimates. Journal of Clinical Oncology. 31(28), 3565-3571. [Abstract]
  • Thientosapol, E., Tran, T., Della-Fiorentina, S., Adams, D., Chantrill, L., Stockler, M., Kiely, B. (2013), Survival times of women with metastatic breast cancer starting first-line chemotherapy in routine clinical practice versus contemporary randomised trials. Internal Medicine Journal. 43(8), 883-888. [Abstract]
  • Kiely, B., McCaughan, G., Christodoulou, S., Beale, P., Grimison, P., Trotman, J., Tattersall, M., Stockler, M. (2013), Using scenarios to explain life expectancy in advanced cancer: attitudes of people with a cancer experience. Supportive Care in Cancer. 21(2), 369-376. [Abstract]


  • Lord, S., Marinovich, M., Patterson, J., Wilcken, N., Kiely, B., Gebski, V., Crossing, S., Roder, D., Gattellari, M., Houssami, N. (2012), Incidence of metastatic breast cancer in an Australian population-based cohort of women with non-metastatic breast cancer at diagnosis. Medical Journal of Australia. 196(11), 688-692. [Abstract]
  • Kiely, B., Alam, M., Blinman, P., Tattersall, M., Stockler, M. (2012), Estimating typical, best-case and worst-case life expectancy scenarios for patients starting chemotherapy for advanced non-small-cell lung cancer: A systematic review of contemporary randomized trials. Lung Cancer. 77(3), 537-544. [Abstract]
  • Kiely, B., Stockler, M. (2012), ACP Journal Club. Meta-analysis: adjuvant tamoxifen reduces recurrence and death at 15 years in ER-positive early breast cancer. Annals of Internal Medicine. 156(6), JC3-4. [Abstract]


  • Kiely, B., Hossack, L., Shadbolt, C., Davis, A., Cassumbhoy, R., Moodie, K., Antill, Y., Mitchell, G. (2011), Practicalities of developing a breast magnetic resonance imaging screening service for women at high risk for breast cancer. ANZ Journal of Surgery. 81(10), 688-693. [Abstract]
  • Kiely, B., Stockler, M., Tattersall, M. (2011), Thinking and talking about life expectancy in incurable cancer. Seminars in Oncology. 38(3), 380-385. [Abstract]
  • Kiely, B., Wilcken, N., Stockler, M. (2011), Life after adjuvant chemotherapy for breast cancer: the news is mostly good. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29, 1092-1093. [Abstract]
  • Kiely, B., Soon, Y., Tattersall, M., Stockler, M. (2011), How Long Have I Got? Estimating Typical, Best-Case, and Worst-Case Scenarios for Patients Starting First-Line Chemotherapy for Metastatic Breast Cancer: A Systematic Review of Recent Randomized Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(4), 456-63. [Abstract]